Cargando…
PLAC8 promotes adriamycin resistance via blocking autophagy in breast cancer
Adriamycin (ADM) is currently one of the most effective chemotherapeutic agents in breast cancer treatment. However, growing resistance to ADM could lead to treatment failure and poor outcome. PLAC8 was reported as a novel highly conserved protein and functioned as an oncogene or tumour suppressor i...
Autores principales: | Chen, Yongxia, Jia, Yunlu, Mao, Misha, Gu, Yifeng, Xu, Chenpu, Yang, Jingjing, Hu, Wenxian, Shen, Jun, Hu, Dengdi, Chen, Cong, Li, Zhaoqing, Chen, Lini, Ruan, Jian, Shen, Peng, Zhou, Jichun, Wei, Qun, Wang, Linbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278087/ https://www.ncbi.nlm.nih.gov/pubmed/34117724 http://dx.doi.org/10.1111/jcmm.16706 |
Ejemplares similares
-
Regulation of tamoxifen sensitivity by the PLAC8/MAPK pathway axis is antagonized by curcumin-induced protein stability change
por: Mao, Misha, et al.
Publicado: (2021) -
Multifaced roles of PLAC8 in cancer
por: Mao, Misha, et al.
Publicado: (2021) -
The novel KLF4/PLAC8 signaling pathway regulates lung cancer growth
por: Jia, Yunlu, et al.
Publicado: (2018) -
Targeting ferroptosis in breast cancer
por: Li, Zhaoqing, et al.
Publicado: (2020) -
PLCA8 suppresses breast cancer apoptosis by activating the PI3k/AKT/NF‐κB pathway
por: Mao, Misha, et al.
Publicado: (2019)